Table of Content

Open Access iconOpen Access

RETRACTION

Retraction notice to “miR-522-3p Promotes Tumorigenesis in Human Colorectal Cancer via Targeting Bloom Syndrome Protein” [Oncology Research 26(7) (2018) 1113–1121]

Feng Shuai*, Bo Wang, Shuxiao Dong

* Department of Gastroenterology, Eastern District of Linyi People’s Hospital, Linyi, Shandong, P.R. China
† Department of Pediatrics, Chinese Medicine Hospital in Linyi City, Linyi, Shandong, P.R. China
‡ Department of Gastrointestinal Surgery, Linyi People’s Hospital, Linyi, Shandong, P.R. China

Oncology Research 2020, 28(9), 977-977. https://doi.org/10.3727/096504021X16297183140281

Abstract

This article has no abstract.

Cite This Article

APA Style
Shuai, F., Wang, B., Dong, S. (2020). Retraction notice to “mir-522-3p promotes tumorigenesis in human colorectal cancer via targeting bloom syndrome protein” [oncology research 26(7) (2018) 1113–1121]. Oncology Research, 28(9), 977-977. https://doi.org/10.3727/096504021X16297183140281
Vancouver Style
Shuai F, Wang B, Dong S. Retraction notice to “mir-522-3p promotes tumorigenesis in human colorectal cancer via targeting bloom syndrome protein” [oncology research 26(7) (2018) 1113–1121]. Oncol Res. 2020;28(9):977-977 https://doi.org/10.3727/096504021X16297183140281
IEEE Style
F. Shuai, B. Wang, and S. Dong "Retraction notice to “miR-522-3p Promotes Tumorigenesis in Human Colorectal Cancer via Targeting Bloom Syndrome Protein” [Oncology Research 26(7) (2018) 1113–1121]," Oncol. Res., vol. 28, no. 9, pp. 977-977. 2020. https://doi.org/10.3727/096504021X16297183140281



cc This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 508

    View

  • 316

    Download

  • 0

    Like

Share Link